These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21468213)

  • 1. Methotrexate supports in vivo selection of human embryonic stem cell derived-hematopoietic cells expressing dihydrofolate reductase.
    Gori JL; McIvor RS; Kaufman DS
    Bioeng Bugs; 2010; 1(6):434-6. PubMed ID: 21468213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase.
    Gori JL; Tian X; Swanson D; Gunther R; Shultz LD; McIvor RS; Kaufman DS
    Gene Ther; 2010 Feb; 17(2):238-49. PubMed ID: 19829316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protection of activated Tyr22-dihydrofolate reductase gene-modified canine T lymphocytes from methotrexate.
    Gori JL; Beard BC; Williams NP; Ironside C; Swanson D; Scott McIvor R; Kiem HP
    J Gene Med; 2013; 15(6-7):233-41. PubMed ID: 23666780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
    Gori JL; Podetz-Pedersen K; Swanson D; Karlen AD; Gunther R; Somia NV; McIvor RS
    J Pharmacol Exp Ther; 2007 Sep; 322(3):989-97. PubMed ID: 17586722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants.
    Meisel R; Bardenheuer W; Strehblow C; Sorg UR; Elmaagacli A; Seeber S; Flasshove M; Moritz T
    Exp Hematol; 2003 Dec; 31(12):1215-22. PubMed ID: 14662327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    James RI; Warlick CA; Diers MD; Gunther R; McIvor RS
    Blood; 2000 Aug; 96(4):1334-41. PubMed ID: 10942375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo.
    Zhao RC; McIvor RS; Griffin JD; Verfaillie CM
    Blood; 1997 Dec; 90(12):4687-98. PubMed ID: 9389683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant.
    Flasshove M; Banerjee D; Bertino JR; Moore MA
    Leukemia; 1995 Oct; 9 Suppl 1():S34-7. PubMed ID: 7475310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
    Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
    J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
    James RI; May C; Vagt MD; Studebaker R; McIvor RS
    Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirally mediated gene transfer of Arg22 and Tyr22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance.
    Braun SE; McIvor RS; Davidson AS; Hanna M; Traycoff CM; Berebetsky DA; Gonin R; Broxmeyer HE; Cornetta K
    Cancer Gene Ther; 1997; 4(1):26-32. PubMed ID: 9012448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a methotrexate-resistant dihydrofolate reductase gene by transformed hematopoietic cells of mice.
    Bar-Eli M; Stang HD; Mercola KE; Cline MJ
    Somatic Cell Genet; 1983 Jan; 9(1):55-67. PubMed ID: 6836451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy.
    Jonnalagadda M; Brown CE; Chang WC; Ostberg JR; Forman SJ; Jensen MC
    PLoS One; 2013; 8(6):e65519. PubMed ID: 23755242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of differential methotrexate toxicity between cells expressing drug-resistant and wild-type dihydrofolate reductase activities in the presence of nucleosides through nucleoside transport inhibition.
    Warlick CA; Sweeney CL; McIvor RS
    Biochem Pharmacol; 2000 Jan; 59(2):141-51. PubMed ID: 10810448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.
    Williams DA; Hsieh K; DeSilva A; Mulligan RC
    J Exp Med; 1987 Jul; 166(1):210-8. PubMed ID: 3298524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.